Dynavax Technologies Corp (DVAX)
11.84
+0.04
(+0.34%)
USD |
NASDAQ |
Apr 22, 16:00
11.84
0.00 (0.00%)
Pre-Market: 20:00
Dynavax Technologies Revenue (TTM): 232.28M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 232.28M |
| September 30, 2023 | 361.18M |
| June 30, 2023 | 459.40M |
| March 31, 2023 | 655.62M |
| December 31, 2022 | 722.68M |
| September 30, 2022 | 733.26M |
| June 30, 2022 | 673.80M |
| March 31, 2022 | 470.10M |
| December 31, 2021 | 439.44M |
| September 30, 2021 | 263.92M |
| June 30, 2021 | 169.07M |
| March 31, 2021 | 118.97M |
| December 31, 2020 | 46.55M |
| September 30, 2020 | 37.57M |
| June 30, 2020 | 34.73M |
| March 31, 2020 | 40.36M |
| December 31, 2019 | 35.22M |
| September 30, 2019 | 29.97M |
| June 30, 2019 | 20.85M |
| March 31, 2019 | 13.81M |
| December 31, 2018 | 8.198M |
| September 30, 2018 | 2.901M |
| June 30, 2018 | 1.493M |
| March 31, 2018 | 0.344M |
| December 31, 2017 | 0.327M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.598M |
| June 30, 2017 | 7.707M |
| March 31, 2017 | 10.25M |
| December 31, 2016 | 11.04M |
| September 30, 2016 | 4.436M |
| June 30, 2016 | 5.462M |
| March 31, 2016 | 4.365M |
| December 31, 2015 | 4.05M |
| September 30, 2015 | 5.642M |
| June 30, 2015 | 6.663M |
| March 31, 2015 | 8.161M |
| December 31, 2014 | 11.03M |
| September 30, 2014 | 6.464M |
| June 30, 2014 | 7.182M |
| March 31, 2014 | 7.526M |
| December 31, 2013 | 6.113M |
| September 30, 2013 | 6.271M |
| June 30, 2013 | 6.218M |
| March 31, 2013 | 5.51M |
| December 31, 2012 | 5.775M |
| September 30, 2012 | 19.34M |
| June 30, 2012 | 17.64M |
| March 31, 2012 | 22.22M |
| December 31, 2011 | 21.61M |
| September 30, 2011 | 11.95M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
20.85M
Minimum
Jun 2019
733.26M
Maximum
Sep 2022
291.84M
Average
232.28M
Median
Dec 2023
Revenue (TTM) Benchmarks
| Supernus Pharmaceuticals Inc | 607.52M |
| Ligand Pharmaceuticals Inc | 131.31M |
| Pacira BioSciences Inc | 674.98M |
| Esperion Therapeutics Inc | 116.33M |
| PetIQ Inc | 1.102B |